Comparison of thrombocytopenia between patients with non-alcoholic fatty liver disease and those with hepatitis C virus-related chronic liver disease.

Naohiko KinoshitaToshihide ShimaKei TerasakiHirohisa OyaTakayuki KatayamaJunko MatsumotoYasuhide MitsumotoMasayuki MizunoChiemi MizunoRina HirohashiKyoko SakaiTakeshi Okanoue

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)

NAFLD patients had a significantly higher platelet count than CLD-C patients following stratification according to the liver fibrosis stage. The milder hypersplenism and higher platelet production in NAFLD than CLD-C may have contributed to this difference.

Keyphrases

end stage renal disease
hepatitis c virus
liver fibrosis
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes
human immunodeficiency virus